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The DNA-binding transcription factor Smad-interacting protein-1 (Sip1) (also named Zfhx1b/ZEB2) plays essential roles in vertebrate
embryogenesis. In Xenopus, XSip1 is essential at the gastrula stage for neural tissue formation, but the precise molecular mechanisms that underlie
this process have not been fully identified yet. Here we show that XSip1 functions as a transcriptional repressor during neural induction. We
observed that constitutive activation of BMP signaling prevents neural induction by XSip1 but not the inhibition of several epidermal genes. We
provide evidence that XSip1 binds directly to the BMP4 proximal promoter and modulates its activity. Finally, by deletion and mutational
analysis, we show that XSip1 possesses multiple repression domains and that CtBPs contribute to its repression activity. Consistent with this,
interference with XCtBP function reduced XSip1 neuralizing activity. These results suggest that Sip1 acts in neural tissue formation through direct
repression of BMP4 but that BMP-independent mechanisms are involved as well. Our data also provide the first demonstration of the importance
of CtBP binding in Sip1 transcriptional activity in vivo.
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doi:10.1016/j.ydbio.2007.02.045inhibition of BMP signaling in the ectoderm is required for
neural fate acquisition. This BMP inhibition occurs through
distinct mechanisms, including inhibition of BMP ligands by
various secreted ligand-binding proteins, inhibition of transcrip-
tion of the BMP gene itself, and negative modulation of
intracellular signaling by Smad proteins (Munoz-Sanjuan et al.,
2002; De Robertis and Kuroda, 2004; Linker and Stern, 2004;
Stern, 2005). Downstream of neural induction, the intracellular
components that establish neural cell fate are not well
characterized. Several neural effectors have been identified
such as Geminin (Kroll et al., 1998), Zic1 to 3 (Nakata et al.,
1997; Kuo et al., 1998), Sox1 to 3 (Penzel et al., 1997; Kishi et
al., 2000; Bylund et al., 2003; Graham et al., 2003), SoxD
(Mizuseki et al., 1998a,b), and the Smad-binding protein Sip1
35L.A. van Grunsven et al. / Developmental Biology 306 (2007) 34–49(Eisaki et al., 2000; van Grunsven et al., 2000; Sheng et al.,
2003).
Sip1 (Zfhx1b/Zeb2) belongs to the Zfhx1 family of multi-
domain transcriptional repressors characterized by a homeo-
domain-like domain and by two zinc finger clusters each of
which binds with high affinity to CACCTG and CACANNTG
binding sites and can form complexes with Smads (Remacle
et al., 1999; Verschueren et al., 1999), the co-repressor CtBP
(C-terminal binding protein) (Postigo and Dean, 2000; van
Grunsven et al., 2003), and the co-activators p300 and
pCAF (p300/CBP associated factor) (van Grunsven et al.,
2006).
In embryos of Xenopus, chick and mouse, Sip1 mRNA is
detected at gastrula in the prospective neurectoderm (Eisaki et
al., 2000; van Grunsven et al., 2000; Sheng et al., 2003; Van de
Putte et al., 2003). Homozygotic deletion of Sip1 in the mouse
is embryonic lethal and the embryos show severe neural crest
cell defects and fail to generate or maintain intact neuralFig. 1. XSip1 acts as a repressor during neural differentiation of the ectoderm. Whole-
14). Embryos were injected at the four-cell stage with the indicated RNA. (A–D) Inj
does not induce Sox2 in animal caps. (E, F) Embryos injected with 250 pg of XSip1
performed to reveal distribution of the injected RNA. Note the expansion of Sox2 ex
reduction in the XSip1-VP16 injected embryo. (G–I) Animal caps derived from em
250 pg of XSip1-VP16 RNA. XSip1-VP16 prevents induction by XSip1 or tBR of So
0%, n=44; (E) 80% embryos with expanded Sox2, n=18; (F) 100% embryos with dectoderm (Van de Putte et al., 2003). In human, mutations in
ZFHX1B exon coding sequences, most of which cause C-
terminal truncation of the protein, lead to Mowat–Wilson
Syndrome (Mowat et al., 2003).
Although Sip1 has been documented primarily as a
transcriptional repressor (Verschueren et al., 1999; Comijn et
al., 2001; van Grunsven et al., 2003; Vandewalle et al., 2005), it
can also act as a transcriptional activator in vivo (Long et al.,
2005; Yoshimoto et al., 2005). Overexpression of Sip1 in
certain epithelial cells induces epithelial to mesenchymal
transition by directly repressing E-cadherin (Comijn et al.,
2001) and other genes coding for crucial proteins of epithelial
cell–cell junctions (Vandewalle et al., 2005). In animal cap
explants of Xenopus early embryos, ectopic synthesis of XSip1
induces neural specific gene expression and represses in the
embryo the expression of the panmesodermal marker gene
brachyury (Xbra), of BMP4 and of other genes in the
presumptive epidermis (Eisaki et al., 2000; Lerchner et al.,mount in situ analysis of Sox2 expression in embryos (St. 11) or animal caps (St.
ection of 250 pg of XSip1-VP16, in contrast to wild-type XSip1 and XSip1-EnR,
-VP16 or XSip1-EnR RNA. LacZ RNAwas co-injected and X-gal staining was
pression on the injected area in the XSip1-EnR injected embryo (arrow) and the
bryos co-injected with 50 pg of XSip1 RNA or 200 pg tBR RNA together with
x2. Respective inductions (A) 100%, n=28; (B) 0%, n=29; (C) 90%, n=30; (D)
ownregulation of Sox2, n=40; (G) 0%, n=35; (H) 100%, n=26; (I) 0%, n=35.
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XSip1 knockdown studies have been performed indicating that,
like in the mouse, Sip1 is essential for neural differentiation
(Nitta et al., 2004).
Despite the demonstrated importance of Sip1 in neural tissue
formation, the underlying molecular mechanism(s) by which it
contributes to neural differentiation remain unknown. In
particular, the in vivo significance of the CtBP interaction in
Sip1-neuralizing activity has not been demonstrated (van
Grunsven et al., 2003). Here we show first that XSip1 functions
as a repressor, blocking directly the transcription of the BMP4
gene. Besides BMP4, XSip1 also represses the transcription of
other epidermal genes in an BMP-independent manner in the
deep and superficial layer of the ectoderm to maintain a neural
fate. Secondly, we demonstrate for the first time the significance
of CtBP interaction for Sip1 activity.
Experimental procedures
Plasmid constructs
All point mutations and deletion mutants of XSip1 were generated by
standard PCR and cloning techniques and their sequences verified. Deletion
mutations of XSip1 were cloned in-frame with six Myc tags and the SV40 T-
antigen nuclear localization signal (NLS) in pCS2-NLS-Myc. Full-length
cDNAs with point mutations were cloned into pCS2-Myc. Amino acid changes
or deletions are depicted in the respective figures except for XSip13xCtBPmut in
which the 3 CtBP sites (i.e. PLNLS786–790, PLDLT816–820, and PLNLT860–864)
were all mutated into AAALS or AAALT. For the XSip1SBDmut, we replaced the
nucleotides coding for amino acids 467 to 488 by insertion of a linker resulting
in AAA in XSip1SBDmut. For the generation of pCS2 NLS Myc XSip1-EnR,
nucleotides corresponding to XSip1 (aa 205–1082) were taken from pCS2 NLS
XSip1205–1082 and ligated into the StuI restriction site of pCS2 NLS EnR. pCS2
Flag mCtBP2 was constructed by insertion of CtBP2, from pCDNA3 Flag
mCtBP2 (van Grunsven et al., 2003), into the StuI restriction site of pCS2. pCS2
VP16-mCtBP2 was generated by cloning the full open reading frame of
mCtBP2 in frame with VP16 in the pAct vector (Promega) and subsequent
subcloning the entire VP16-mCtBP2 coding region into the StuI site of pCS2.
The XSip1 NZF-CtBP and NZF-GFP expression constructs were obtained by
cloning the full open reading frames of mCtBP2 and eGFP (Invitrogen),
respectively, in-frame with the NZF of XSip1-NZF(XSip1198–344 in Fig. 4A).
Previously described expression constructs used here are: CA-Alk3 (Onichtch-
ouk et al., 1999), tBR (Suzuki et al., 1994), XSip1 (van Grunsven et al., 2000),
mSip1-CZFmut-CID and mCtBP2 (van Grunsven et al., 2003), and XSip1-VP16
(Papin et al., 2002). For the CZFmut-CIDmut, the CID domain in the mSip1-
CZFmut-CID construct was replaced by a CID domain with mutated CtBP
binding sites (van Grunsven et al., 2003).
Xenopus embryo manipulations and injections
Xenopus embryos were obtained from adult frogs by hormone induced
egg-laying and in vitro fertilization, using standard methods (Sive et al.,Fig. 2. Effect of BMP signaling on XSip1 activity. (A–I) Animal caps derived from
(A), XSip1 RNA (B, C, E–I) or XSip1ΔSBD mRNA (D) with or without CA-Alk3 RN
probes. For each marker, control non-injected animal caps are shown on the left. N
neurula stage (dorsal view, anterior right) are shown on the right. Note that CA-Alk3 b
and the repression of Gata2 expression (E). In contrast, CA-Alk3 does not affect XSi
Hya-1 and Vgl-4 (E–I). (J) Lateral views of embryos injected with XSip1 RNA alone
of CA-Alk3 does not affect XSip1 repression of epidermal keratin. Respective inducti
inhibited, n=18; (C) all inhibited, n=52; (D) all inhibited, n=36; (E) none inhibited,
(J) all inhibited, n=33. Arrows in panels E–J indicate the injected area.2000), and staged according to Nieuwkoop and Faber (1997). Capped
transcripts were synthesized in vitro by using the mMessage mMachine kit
(Ambion, Austin, TX). RNA or antisense morpholino oligonucleotides (20/
blastomere of CtBP MO; 5′-GCCTCTTCACTTTGTGTTTATCCAT-3′) (Gene
Tools LLC) were injected as described and at the indicated stage. Synthetic
nuc-LacZ RNA (from 100 to 500 pg), encoding a nuclear form of β-
galactosidase, was used as a lineage tracer. Animal cap explants were
prepared at late blastula (stage 9.5) and cultured in 1× Steinberg medium
supplemented with 0.1% BSA (Steinberg–BSA) until neurula stage.
Trichostatin A (33 mM) was diluted 1:66,200 in 1× Steinberg–BSA for use
in the animal cap explants.
RT-PCR
The Qiagen Rneasy mini kit was used for RNA isolation from embryos at
different developmental stages. All RNA preparations were treated with DNAse I
(Qiagen) and checked with 32 cycles of Histone H4 for DNA contamination. RT-
PCRwas carried out as described in the GeneAmpRNAPCRkit (Perkin-Elmer).
The following primers were used:
Histone H4, (F) 5′-CGGGATAACATTCAGGGTATCACT-3′, (R) 5′-
ATCCATGGCGGTAACTGTCTTCCT-3′; 56 °C, 25 cycles; XSip1, (F) 5′-
ATGCAGCACTTAGGTGTAGGGATGG-3′, (R) 5′-GTTGATGCAATG-
GAATTGGAC; CAGG-3′; 57 °C, 35 cycles; XCtBP, (F) 5′-
AGTGAAGAGGCAACGTTTGG-3′, (R) 5′-CGAGAAAGTGT-
GATTGTGTG-3′; 57 °C, 33 cycles; XCtBP1, (F) 5′-GTTCTCACTTGC-
TAAACAAGG-3′, (R) 5′-TGAACTTCTCCAGACTTCCC-3′; 57 °C, 33
cycles; BMP4, (F) 5′-GAGGAGCATTTGGAGAATCTACCAA-3′, (R) 5′
CATAATTGCAGGGCTTACATCAA; 56 °C, 25 cycles; Sox2, (F) 5′-
GAGGATGGACACTTATGCCCAC-3′, (R) 5′-GGACATGCTGTAGG-
TAGGCGA-3′; 56 °C, 25 cycles.
PCR products were separated on 2% agarose gels and visualized by staining
with ethidium bromide.
RNase protection assay
RNAwas prepared with the phenol/NETS method and analyzed using 32P-
labeled probes as previously described (Lahaye et al., 2002). RNase protection
probe for Ep. Keratin was generated by linearizing pGEM81B plasmid (Jonas et
al., 1985) by NarI and transcribing it with Sp6. The protected fragment is 270
bases long. A 230 bp Sox2 probe was obtained by linearizing a pBS SK(−)-Sox2
plasmid (Mizuseki et al., 1998a,b) by NcoI and transcribing it with T7. An rFGF
antisense probe (Ryan et al., 1998) was used as a loading control.
In situ hybridization
Embryos were fixed in MEMFA, stained for β-galactosidase activity with 5-
bromo 4-chloro-3-indolyl-β-galactopyranoside (X-Gal), and processed for in
situ hybridization using digoxygenin-labeled antisense RNA probes (Sive et al.,
2000). To produce the XCtBP probe, the cDNA was linearized by SmaI and
transcribed with T7 (pExpress XCtBP obtained from Biocat GmBH; Genbank
accession no. BC076800). For the XCtBP1 probe the cDNAwas linearized with
SmaI and transcribed with T7 (pCMV Sport6 XCtBP1 obtained from Biocat
GmBH; Genbank accession no. AF091554). Plasmids used for generating the
other probes for in situ hybridization were as described previously: Xbra (Smithembryos injected at the four cell-stage (250 pg/blastomere) with Geminin RNA
A (100 pg) analyzed at neurula stage by in situ hybridization with the indicated
on-injected control embryos and CA-Alk3 RNA-injected (100 pg) embryos at
locks XSip1's ability to induce the neuronal markers Sox2 and NCAM (B and C)
p1's ability to block several other epidermal genes like epidermal keratin, TA-2,
or together with CA-Alk3 RNA and stained for epidermal keratin. Co-expression
ons/inhibitions in “+CA-Alk3 caps and embryos”: (A) all positive, n=35; (B) all
n=40; (F) all inhibited, n=22; (G) all inhibited, n=25; (H) all inhibited, n=28;
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Gata2 (Walmsley et al., 1994), Sox2 (Kishi et al., 2000), Sox3 (Penzel et al.,
1997), NCAM (Krieg et al., 1989), XSip1 (van Grunsven et al., 2000), Grainy-
head (Tao et al., 2005), TA-2, Hayluronan synthase 1 and vestigial like 4
(Chalmers et al., 2002). For sections, after completion of the whole-mount
procedure, the embryos were gelatin-embedded and vibratome-sectioned at
30 μm thickness.
Cell culture, transient transfections and immunoprecipitations
For BMP4 reporter assays, HEK293T cells were cultured in DMEM
supplemented with 10% fetal clone (Invitrogen). Transient reverse transfections
were carried out in 96-well plates (5×104 cells/well) using Fugene6 and a total
of 100 ng DNA per well. Two nanograms of a LacZ reporter construct that
contains the cytomegalovirus promoter inserted upstream of E. coli LacZ was
cotransfected for normalization. Cell extracts were prepared and assayed using a
Luminoskan Ascent (Labsystems) for luciferase and β-galactosidase activity
according to the manufacturers' protocols (Luciferase assay system (Promega)
and Galscreen™ (Tropix)), and only transfections with similar β-galactosidase
values were taken into account. The data, obtained in triplicate experiments,
were then normalized by calculating the ratio of luciferase and β-galactosidase
activities. Each experiment was repeated at least 5 times. For Western analysis,
one fifth of the cell lysate was run on an 8% SDS–PAGE gel followed by
Western detection of the produced proteins by means of anti-Myc antibodies and
subsequent visualization using the Western lightning detection system (Perkin-
Elmer). Immunoprecipitation of Sip1–CtBP complexes from transfected
HEK293T cells was carried out as described previously (van Grunsven et al.,
2006).
Electrophoretic mobility shift assays
In vitro-translated proteins were prepared using the TNT coupled
transcription–translation system (Promega). Gel mobility shift assays were
carried out with PCR products obtained using the 2 kb XBMP4 promoter
(Genbank accession no. XLAJ5076) as a template and the following primers:
Probe 1 (F) 5′-GCCCCAATGGCCCTTTAA-3′, (R) 5′-CGTGAAA-
CACCTGGCATGTTT-3′. Probe 2 (F) 5′-CGAAGGCTGAGGTGAGCAA-3′,
(R) 5′-TGGTCGTGCCAATCCTATT CT-3′; Probe 3 (F) 5′-GGAATG-
TGTGTCCAGTAGCTGATT-3′, (R) 5′-TGTAAAGATCAACAATACTGT-
GAATAAATTG-3′. The PCR products were labeled using T4 DNA kinase in
the presence of [γ-32P] dATP. Protein–DNA complexes were formed by
incubation of the proteins with 50,000 CPM (about 0.1 ng) of radioactively
labeled DNA for 20 min at 24 °C in 20 μl of binding buffer (10 mM Tris–HCl
pH 7.5, 150 mM KCl, 1 mM DTT, 10% glycerol, 0.1% NP40, 0.2 mg BSA/ml
and 0.5 μg polydI–dC/ml). DNA–protein complexes were resolved by
electrophoresis on a 4% acrylamide gel in 0.5× TBE buffer. The dried gel
was exposed to X-ray film overnight at −80 °C with an intensifying screen.Results
XSip1 acts as a repressor during neural differentiation
Previous studies showed that Sip1 can act both as a repressor
and an activator of transcription (Verschueren et al., 1999; Comijn
et al., 2001; Long et al., 2005; Yoshimoto et al., 2005; van
Grunsven et al., 2006). To determine the transcriptional activity of
XSip1 responsible for neural induction in Xenopus embryos, we
used chimeric proteins in which XSip1 (as full-length protein or a
polypeptide containing both zinc finger clusters) is fused to the
herpes simplex virus VP16 activator domain (Papin et al., 2002)
or the Drosophila Engrailed repressor domain (Jaynes and
O'Farrell, 1991). The neural-inducing activities of the VP16
activator fusion (XSip1-VP16) and the Engrailed repressor fusion
protein (XSip1-EnR) were examined by overexpression in animalcap explants and in embryos. In animal caps, overproduction of
XSip1 and XSip1-EnR induced the expression of the early neural
marker Sox2, whereas XSip1-VP16 did not have this effect (Figs.
1A–D). Similar results were obtained using a later neural marker,
NCAM (data not shown). In embryos, overproduction of XSip1-
EnR, like XSip1 (van Grunsven et al., 2006), expanded Sox2
staining on the injected side whereas XSip1-VP16 inhibited Sox2
expression (Figs. 1E, F). Previously, XSip1-VP16 has been
shown to induce the expression of the mesodermal marker Xbra
in animal caps (Papin et al., 2002) using RNAase protection
assays. Since this could explain the inhibition of Sox2 we
observed in embryos, we re-examined XSip1-VP16 injected
embryos and animal cap explants for Xbra expression. Surpris-
ingly, we found that XSip1-VP16 does not induce Xbra
expression, as detected by in situ hybridization or RT-PCR.
Moreover, in embryos, Xbra expression was inhibited by XSip1-
VP16 (data not shown) as is the case for overexpression of the
native protein (Papin et al., 2002; van Grunsven et al., 2006).
Thus, the downregulation of Sox2 expression by XSip1-VP16
might not be due to conversion of ectoderm into mesoderm and
may reflect the upregulation of putative downstream targets of
XSip1 that are normally inhibited during neural tissue formation.
To assess the potential inhibitory effect of XSip1-VP16 in
neural differentiation, XSip1-VP16 was co-expressed with
native XSip1 or a dominant negative BMP receptor (tBR)
(Suzuki et al., 1994) and the induction of Sox2 was examined.
As expected, both XSip1 and tBR induced Sox2 (Figs. 1A, H),
while this response was fully inhibited by XSip1-VP16 (Figs.
1G, I). Taken together, the similarity of the effects of XSip1 and
XSip1-EnR and the opposite effects of the XSip1-VP16
construct suggests that XSip1 is likely to function as a repressor
to induce neural differentiation. Our data also extend previous
observations indicating that XSip1 has an essential role in early
neural gene expression (Nitta et al., 2004).
XSip1 neuralizes ectoderm through BMP inhibition but also
has a BMP independent function in the suppression
of epidermal fate
In animal caps cut from XSip1 overexpressing embryos, the
neural markers Sox2, Sox3 and NCAM are induced, whereas
epidermal markers and BMP4 expression are suppressed (Eisaki
et al., 2000; Postigo et al., 2003; Nitta et al., 2004; van
Grunsven et al., 2006). These observations are consistent with a
mechanism in which downregulation of BMP4 RNA levels is
the primary means by which XSip1 induces neural tissue. If so,
co-injection of CA-Alk3 RNA, encoding a constitutively active
BMP type I receptor, should block neuralization and rescue
epidermalization. In our experiments, we injected 100 pg of
CA-Alk3 per blastomere into 2 cell-stage embryos, an amount
that was sufficient to induce ectopic staining within the neural
plate of all epidermal markers tested and that could relieve
suppression of epidermal development induced by overexpres-
sion of other epidermal inhibitors such as geminin (Kroll et al.,
1998) (Fig. 2A and right panels in E–I). Higher doses were also
tested but could not be used in our assays as they were found for
unknown reasons to inhibit epidermal gene expression (data not
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XSip1 RNA blocked XSip1's ability to induce Sox2 and NCAM
in animal cap explants (Figs. 2B, C and data not shown).
Interestingly, co-expression of CA-Alk3 with a XSip1 mutant
unable to bind to Smads (XSip1ΔSBD) also blocked induction
of Sox2 (Fig. 2D). This suggests that the inhibition observed is
not due to direct interaction of BMP-activated phosphorylated
Smads with XSip1 but probably involves indirect convergence
of Smad signals and XSip1 on target gene promoters. Co-Fig. 3. Repression of the BMP4 promoter by Sip1. (A) Schematic representation of th
number XLAJ5076). Putative Sip1 binding sites are indicated by vertical stripes. The
base pairs of exon1 of XBMP4 are represented by a dark gray box. (B) The N-term
promoter. In vitro transcribed-translated proteins were incubated with the indicated
indicate the XSip1 specific shift in migration of the labeled probes. The shift is not
XBMP4 fragments, but not by XBMP4 fragments with mutated CACCT sites. (C
analyzed 40 h later for the XBMP4 promoter-driven luciferase activity. β-Galactos
manner the activity of the indicated 2 kb XBMP4 promoter-luciferase reporter const
reporter construct. Control Western blots for Myc-Sip1 protein content in the transfeinjection of CA-Alk3 RNAwith XSip1 RNA affected the ability
of XSip1 to repress Gata2, a marker of both superficial and
deep layers of the ventral ectoderm, but did not block its ability
to repress other epidermal genes, such as Epidermal keratin,
Grainyhead-like-1 (Tao et al., 2005) and TA-2 that are
selectively expressed in the superficial layer and Vestigial like
4 (Vgl-4) and Hyaluronan synthase 1 (Hya-1) (Chalmers et al.,
2002), which are deep cell specific markers (Figs. 2E–I and data
not shown). Similar results were obtained in embryos (Fig. 2Je BMP4 promoter based reporter construct used in this study (Genbank accession
probes used in panel B are represented by numbered thick horizontal stripes. 54
inal zinc finger cluster of XSip1 can bind to upstream regions of the XBMP4
probes and the complexes were run on a polyacrylamide gel. The arrowheads
observed using another protein, Su(H), and it is blocked by an excess of cold
) The indicated plasmids were transfected into HEK293T cells and the cells
idase corrected luciferase values are given. Sip1 represses in a dose-dependent
ruct. A Sip1 double zinc finger mutant (dbl ZFmut) does not regulate the BMP4
cted cells used for the luciferase assays are shown.
40 L.A. van Grunsven et al. / Developmental Biology 306 (2007) 34–49and data not shown). These results indicate that XSip1's ability
to repress BMP signaling is essential for its neuralizing
properties but that XSip1 also has a BMP independent function
in epidermal inhibition.
Repression of the BMP4 promoter by XSip1
BMP genes, including BMP4, are expressed in a pattern
complementary to the emerging neural plate in gastrula and
neurula embryos (Hemmati-Brivanlou and Thomsen, 1995). To
determine whether XSip1 could regulate BMP4 transcription
directly, we examined the upstream regulatory region of the
Xenopus BMP4 gene. Several CACCT(G) type Sip1 binding
sequences were identified, including in the region that has been
shown to be essential for transcriptional activation of BMP4
(Metz et al., 1998) (Fig. 3A). We first tested in electro mobility
shift assays (EMSA) whether XSip1 could bind in vitro to the
CACCT(G) sequences located in the −488 to +54 bp fragment
of the promoter (the three probes used are indicated by numbers
in Fig. 3A). Fig. 3B shows that a XSip1 truncated protein (with
the NZF zinc fingers) that retains high-affinity and sequence
specific DNA-binding in vitro (Remacle et al., 1999) binds to
each of these probes in a specific manner. Moreover, no binding
to the BMP4 promoter fragments is observed with another
DNA-binding protein, Suppressor of hairless (Su(H)).
To further assess the relevance of the XSip1 binding sites
identified in the BMP4 promoter, we tested in mammalian cells
whether a luciferase reporter gene under the control of a 2 kb-
long XBMP4 promoter fragment is regulated by Sip1. For these
assays, we used mouse Sip1 expression vectors (Remacle et al.,
1999; Verschueren et al., 1999; van Grunsven et al., 2003) that
are conceptually identical to the wild-type and mutant XSip1
constructs used for the Xenopus studies (see below). A dose-
dependent decrease of the activity of the BMP4 promoter region
was observed when plasmids encoding Myc-tagged Sip1
proteins were co-transfected with the BMP4-promoter-based
reporter plasmid. No such decrease was observed using a
double zinc finger Sip1 mutant (Fig. 3C) incapable of binding to
DNA. Similar results were obtained using a shorter (−488 bp)
BMP4 promoter fragment (data not shown). These data suggest
that Sip1 repression of BMP4 transcription is direct.Fig. 4. Mutational analysis of XSip1 reveals multiple regions, including the CtB
representation of XSip1 wild-type protein and mutants used in this study. The amino-
Smad-binding domain (SBD; black box), homeodomain-like domain (HD; dotted box
black stripes) are shown. Embryos injected unilaterally at the two-cell stage (250 pg)
hybridization for epidermal keratin expression. For animal cap assays, embryos were
analyzed at neurula stage by in situ hybridization or RNase protection for Ep. kerat
keratin expression and to induce Sox2 was evaluated based on the RNase protection d
embryos were used for each condition. Note that, with the exception of the XSip1dbl Z
the epidermal keratin repression assay. In contrast, in the Sox2 induction assay, only th
mutants show some Sox2 induction activity, XSip1205–1082 and XSip1CtBPmut. (
overproducing Myc-tagged XSip1 wild-type and several mutant proteins. (C) RNAa
from embryos overeproducing wild-type and several XSip1 mutants. Note that, comp
Ep. keratin repression activity. XSip1198–344 and XSip1993–1082 mutants correspond
hybridization analysis of Sox2 and Ep. keratin expression in animal caps (top panel
Embryos are viewed laterally. Note that, in contrast to XSip1ΔSBD, which functions as
caps and XSip1dbl ZFmut was inactive. Both XSip1ΔSBD and XSip13xCtBPmut, as judge
panel D indicate the injected area.XSip1 possesses multiple repression domains that are required
for efficient neural induction including the CtBP interaction
motif
Although XSip1 binds to Smads and CtBPs (van Grunsven et
al., 2000, 2006), it has not been addressed whether their binding
affects its ability to regulate transcription of target genes during
neural induction. A full-length Sip1 mutant that cannot bind to
CtBP (through mutation of all three binding sites for CtBP) can
still repress endogenous E-cadherin expression in dog kidney
cells (MDCK), suggesting that Sip1 represses target genes
through the recruitment of other co-repressors as well (van
Grunsven et al., 2003). To identify the domains of XSip1
necessary for its neural inducing capacities, we made a series of
XSip1 deletion mutants (Fig. 4A). In addition, we generated
mutants that no longer interact with Smads (XSip1 Δ466–488,
the XSip1ΔSBDmut) or CtBP (XSip13xCtBPmut). The correspond-
ing mouse mutant proteins have been previously characterized
(Verschueren et al., 1999; van Grunsven et al., 2003) (see also
Supplementary Fig. 1). Those tagged point mutant proteins were
synthesized at levels similar to that of the full-length wild-type
XSip1 (Fig. 4B). The XSip1ΔSBD, XSip13xCtBPmut and the
different XSip1 deletion mutants were tested for their ability to
block epidermal keratin expression in embryos by in situ
hybridization and in animal caps by RNase protection. Their
ability to induce Sox2 expression was tested in animal cap
explants by in situ hybridization and RNase protection. As
shown in Figs. 4A–D, binding to DNA is required for XSip1
activity since the XSip1dbl ZFmut, containing mutations in the
third zinc finger of the NZF and CZF cluster (H299S/H1072S,
which are mutations known to lead to loss of high-affinity DNA
binding of mouse Sip1 in vitro) (Remacle et al., 1999), failed to
induce Sox2 and to repress epidermal keratin. The zinc finger
clusters alone (XSip1198–344 and XSip1993–1082) were neither
sufficient to induce Sox2, nor to block epidermal keratin,
indicating that XSip1's activities do not depend merely on the
occupation of DNA sequences that can be bound by transcrip-
tional activators. Removal of the N-terminal and C-terminal
non-finger sequences (XSip1205–1082) reduced XSip1's ability to
induce Sox2, indicating that one or both of those regions
contribute to XSip1 activity. Although less active than the nativeP interaction domain, involved in XSip1 repression activity. (A) Schematic
terminal and carboxy-terminal zinc finger domains (NZF and CZF; gray boxes),
), C3H type zinc finger (light gray boxes) and the CtBP interacting domain (CID:
overproducing wild-type XSip1 or mutants were tested at neurula stage by in situ
injected at the four-cell stage in each cell (250 pg/blastomere). Animal caps were
in and Sox2 expression. The ability of the different XSip1 mutants to block Ep.
ata: (+) fully active, (+/−) partially active, and (−) not active. A minimum of 30
Fmut, and NZF or CZF alone mutants, all mutants are active, fully or partially, in
e XSip1 wild-type and XSip1ΔSBD polypeptides are fully active. Only two other
B) Control Western blot with extracts prepared from injected animal caps
se protection analysis of Sox2 and Ep. keratin expression in animal caps derived
ared to the wild-type protein, XSip1205–1082 shows reduced Sox2 induction and
ing to the first and second zinc finger domains alone are not active. (D) In situ
s) and embryos (bottom panels) that overproduce the indicated XSip1 proteins.
the native XSip1 protein, XSip13xCtBPmut induced less efficiently Sox2 in animal
d by in situ hybridization, retain epidermal keratin repression activity. Arrows in
41L.A. van Grunsven et al. / Developmental Biology 306 (2007) 34–49XSip1 protein, this XSip1205–1082 mutant was still able to induce
Sox2 expression and to repress epidermal keratin, indicating that
the inter-zinc finger domain also plays a role in XSip1 repression
activities (Fig. 4C). Other deletion mutant proteins tested,
retaining only one of the two zinc finger clusters and flanking
amino or carboxy-terminal sequences, failed to neuralize ecto-
derm (i.e. XSip11–333 and XSip1993–1213, XSip1469–1213 and
XSip11–468) which may be due to the fact that both zinc fingerclusters might be required for high-affinity binding to bipartite
target sequences and thus for full repressor activity (Remacle
et al., 1999). Although unable to neuralize ectoderm, all those
mutants still had, at least to some extent, epidermal keratin
repression activity, suggesting that the non finger portion
present in those mutants also contribute to XSip1 repression
activities. Interestingly, the XSip13xCtBPmut was also less active
in our Sox2 and epidermal keratin assays while the SBD
42 L.A. van Grunsven et al. / Developmental Biology 306 (2007) 34–49mutant showed similar activities as the wild-type protein in
both assays (Figs. 4D and 7B).
As XSip1 and several of the mutants tested could inhibit
epidermal keratin expression without inducing Sox2, we asked
whether cells overexpressing XSip1, or some deletion mutants
showing reduced repression activity (such as XSip13xCtBPmut),
express neural crest or placodal markers that are known to formFig. 5. Comparison of XSip1, XCtBP, and XCtBP1 expression during embryogenesis.
embryonic stages. Histone H4 was used as a loading control. Note that both XCtBP a
accumulate at the start of zygotic transcription. (B) Whole-mount in situ hybridizatio
with anterior toward the right. (C) XCtBP expression in a horizontal section of a stage
sensorial layer of the ectoderm. Transversal sections of the neural tube at the level of
XCtBP1 have similar expression patterns during early embryonic development an
expressed earlier and at a higher level than XCtBP1. Later, XCtBP and XCtBP1 have
mz, marginal zone; vz, ventricular zone; pn, pronephros; ba, branchial arches; nc,
ectoderm. St. 11 embryos: dorso-vegetal view, anterior right; St. 13 embryos: dorsaunder conditions of intermediate levels of BMP inhibition
(Marchant et al., 1998). We found that ectodermal cells located
at a distance from the neural plate in embryos that were injected
with 250 pg of XSip1 or XSip13xCtBPmut RNA per blastomere
did not adopt a placodal or neural crest identity (see Sup-
plementary Fig. 2). This suggests that BMP inhibition induced
by overexpression of those two proteins was effective enough to(A) RT-PCR analysis of XCtBP, XCtBP1, and XSip1 expression at the indicated
nd XCtBP1 RNA are detected throughout development, while XSip1 transcripts
n of XCtBP, XCtBP1, and XSip1 at the indicated stages. All embryos are shown
18 embryo with a blow-up showing the restricted XCtBP expression in the deep
the hindbrain of stage 31 embryos are shown at the right. Note that XCtBP and
d are co-expressed with XSip1 in the developing neural tissue, XCtBP being
distinct expression domains within the developing neural tube. Abbreviations:
neural crest; nt, neural tube; pm, posterior mesoderm; sl, sensorial layer of the
l view, anterior right; St. 25 and 31 embryos: lateral view, anterior right.
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from forming. The nature of these XSip1 expressing cells that
are neither epidermal nor neural or neural plate border cells
remains unknown. Together, these data indicate that XSip1
possesses multiple repression domains, which when combined
allow it to exceed a critical threshold of repression on target
genes necessary for neural induction, and that CtBPs, but not
Smads, contribute to its repression activity.
Temporal and spatial expression patterns of XCtBP and
XCtBP1
The above results suggest that intact CtBP binding sites are
important for XSip1 to induce Sox2. For this to occur, the genes
encoding CtBP and XSip1 have to be co-expressed during
neural induction. Two CtBP genes have been identified in Xe-
nopus, designated XCtBP1 (Sewalt et al., 1999) and XCtBP,
which is likely to be the homologue of mouse and human
CtBP2 (Brannon et al., 1999). XCtBP is expressed throughout
Xenopus development, but the XCtBP1 expression profile has
not been mapped. We determined whether both CtBP expres-
sion profiles overlap with that of XSip1 during early embryo-
genesis. Using RT-PCR, we found that both XCtBP and
XCtBP1 transcripts are detected maternally and after the start
of zygotic transcription. At all stages examined, XCtBP is
expressed at a much higher level than XCtBP1. As previously
reported, XSip1 transcripts accumulate after mid-blastula
transition (van Grunsven et al., 2000, 2006) (Fig. 5A). In situ
hybridization shows that XSip1 RNA expression in gastrula and
neurula is restricted to the prospective neurectoderm while
XCtBP is broadly expressed in the entire ectoderm, the
strongest signal being detected in the anterior neural plate.
XCtBP transcripts are also seen from neurula stage in the
posterior mesoderm. Sections revealed that, like XSip1 (van
Grunsven et al., 2000), early expression of XCtBP within the
ectoderm is restricted to the deep sensorial layer (Fig. 5C, St.
18). XCtBP1 transcripts are not detectable by in situ hybridiza-
tion during gastrulation and are only weakly detectable in the
anterior portion of the neural plate in the eye field at neurula
stage (Fig. 5B, St. 11 and 13). At tailbud stage, both XCtBP and
XCtBP1 are expressed, like XSip1, in the developing neural
tube, in the eye and migratory cranial neural crest cells (Fig. 5B,
St. 25). At tadpole stage, sections revealed that, while XSip1 is
no longer expressed in the neural tube, XCtBP and XCtBP1
continue to be expressed in the neuroepithelium. While XCtBP
transcripts are located in the ventricular zone, XCtBP1
transcripts are found in the lateral part of the neural tube (Fig.
5C, St. 31). Thus, although both CtBP transcripts are detectable
by RT-PCR during early embryonic development, only XCtBP
is strongly expressed in the developing neurectoderm at the
time of neural induction. This suggests that, among the two
CtBP proteins, XCtBP may be the predominant XSip1
biological partner during neural induction. Later, XCtBP and
XCtBP1 have distinct expression patterns and their expression
differs from that of XSip1 in a number of tissues, which
suggests that they may have unique functions that are XSip1
independent.XCtBP is required for XSip1 neuralization activity
To further investigate the importance of CtBP for XSip1
neuralization activity, we first constructed a chimeric protein in
which mCtBP2 was fused directly to the N-terminal zinc finger
region of XSip1 (NZF-mCtBP2) and tested the ability of this
protein to neuralize ectoderm in embryos and animal cap
explants. Injection of this construct inhibited epidermal keratin
expression and efficiently induced Sox2 expression. This was
not observed when overproducing XCtBP, NZF alone, or a
XSip1-NZF-GFP fusion (Fig. 6A and data not shown). Second,
we generated a chimeric protein in which the C-terminal zinc
finger region of mSip1 was fused to a mouse Sip1 polypeptide
encompassing the CtBP interacting domain (CZF-CID). We
found that this fusion protein, although unable to neuralize
animal caps (data not shown), slightly decreases the level of
expression of epidermal keratin. Overproduction of CZF alone
or a fusion with a mutated CID (CZF-CIDmut) did not have this
effect (Fig. 6B). Third, we examined whether loss or inhibition
of CtBPs affects XSip1 activity. To study CtBPs requirement,
we used three independent and complementary approaches.
First, an out-titration experiment was performed. As shown in
Fig. 6C, co-injection of XSip1 RNA with RNA coding for a
mouse Sip1 CID polypeptide fused to a mutant CZF (abolished
DNA binding) and a nuclear localization signal (CID) (van
Grunsven et al., 2003) reduced XSip1-mediated induction of
Sox2. No such effect was observed upon co-injection with
RNA coding for the same polypeptide but with mutated CtBP
binding sites (CIDmut). As a second independent method to
interfere with CtBP function, we generated an antimorphic form
of mCtBP2 by fusing it to the VP16 activation domain (CtBP-
VP16) and tested its effect on XSip1 neuralizing activity. As
shown in Fig. 6D, CtBP-VP16 strongly decreased XSip1 ability
to induce Sox2 expression in animal caps. Finally, we designed
a morpholino oligonucleotide complementary to the XCtBP
mRNA at the region of the initiator methionine codon (MO
CtBP). This MO efficiently blocked the translation of XCtBP
mRNA in vitro (Fig. 6E). RNA encoding XSip1 was injected
alone or together with XCtBPMO. Fig. 6E shows that induction
of Sox2 expression by XSip1 was reduced by co-injection of
XCtBP MO. Co-injection of wild-type mouse CtBP2 RNA
partially restored Sox2 expression, indicating that the loss of
Sox2 expression is specific to the reduction of CtBP activity.
One way by which CtBPs are known to mediate repression is
through histone modification. As CtBPs are part of a complex
containing histone deacetylases (HDACs) (Shi et al., 2003), we
investigated whether XSip1 activity in neural induction involves
histone deacetylation. To this end, we cultured XSip1-over-
producing animal caps in the presence of 400 nM of the HDAC
inhibitor trichostatin A (TSA). Treatment with TSA completely
blocked the ability of XSip1 to induce Sox2 (Fig. 6F) suggesting
that XSip1 represses gene function during neural tissue
formation in an HDAC-dependent manner. This inhibitory
effect is not a toxic effect as genes such as H4 and EF1α are
normally expressed in TSA treated caps (data not shown) (Kao et
al., 1998; Koyano-Nakagawa et al., 1999). Together, these
results indicate that the neuralizing activity of XSip1 is CtBP-
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manner.
XCtBP is required for XSip1 repression of BMP4
As the ability of Sip1 to repress BMP4 is crucial for its
neuralizing activity, we asked whether CtBP binding is required
for Sip1-mediated BMP4 repression. We first tested this by
comparing the activity of wild-type and CtBP mutant mouse
Sip1 proteins in transfected cells. We observed that co-
transfection of increasing amounts of the mSip13xCtBPmut
expression plasmid, in contrast to the wild-type and the SBD
mutant counterparts, had no effect on the activity of the 2-kb-
long XBMP4 promoter (Fig. 7A). We next compared the
activities of wild-type and CtBP mutant XSip1 proteins on
BMP4 expression in vivo. In animal caps overproducing similar
amounts of wild-type and mutant proteins analyzed by RT-PCR,
XSip13xCtBPmut repressed BMP4 and Ep. keratin expression
less efficiently than the wild-type protein and, in accordance
with the above in situ data, induces less efficiently Sox2 (Fig.
7B). These data suggest that CtBP proteins significantly
contribute to XSip1 neuralizing activity by acting as a co-
repressor of XSip1 for the regulation of BMP4 transcription.
Discussion
Previous studies have shown that Sip1 plays an essential role
during vertebrate early neural development but the likely
multiple mechanisms by which Sip1 exerts its functions remain
unknown (Eisaki et al., 2000; van Grunsven et al., 2000, 2006;
Wakamatsu et al., 2001; Sheng et al., 2003; Van de Putte et al.,
2003; Nitta et al., 2004). We show that XSip1 acts in neural
differentiation as a repressor that inhibits BMP4 transcription
and therefore contributes to the limitation of BMP activity and
subsequent signaling. We also demonstrate an effect of XSip1
on certain epidermal genes unrelated to BMP repression.
Finally, we provide evidence that XSip1 possesses multiple
repression domains and that CtBP interaction is involved in
Sip1 in vivo activity, being required for efficient repression of
BMP4 and induction of neural differentiation.Fig. 6. CtBP dependence of XSip1-mediated neuralizing activity. Whole-mount in s
keratin. (A) Animal caps derived from embryos injected with NZF-CtBP or NZF-GF
with the same RNA analyzed for epidermal keratin expression. (B) Lateral view of N
for Ep. keratin expression. (C) Animal caps derived from embryos injected with XS
RNA (1 ng/blastomere) and analyzed for Sox2 expression. Note that mSip1 CID, but
blot for Myc-XSip1 and Myc-CID content in the animal caps is shown in the right pan
of Sox2 expression. Non-injected controls are shown on the right and XSip1 controls a
RNA (100 pg/blastomere) alone or co-injected with XCtBPMO (20 ng/blastomere) o
Sox2 expression. Caps expressing mCtBP2 alone and embryos analyzed for Sox2 are
analysis of in vitro transcription/translation reactions of XCtBP performed in the pres
injected embryos were cultured from the time of their excision in the presence or abse
Sox2 expression. Note that TSA treatment inhibits the ability of XSip1 to induce Sox2
none for NZF-GFP (n==25); 100% inhibited embryos with NZF-CtBP (n=30); none
for NZF alone (n=30) and for NZF-CIDmut (n=32); (C) 90% with reduced staining
staining (n=40) for XSip1+CtBP-VP16; no staining in control caps (n=30); (E) all s
MO CtBP; 50% with strongly positive, n=30 for XSip1+CtBP MO and mCtBP2; n
none for XSip1+TSA (n=45).By making use of chimeric XSip1 proteins containing a
heterologous and acknowledged transcriptional repressor or
activator domain, we analyzed whether XSip1 functions as an
activator or a repressor during neural differentiation. XSip1-
EnR produced the same phenotype as XSip1 in injected
embryos and animal caps on Sox2 and NCAM, while XSip1-
VP16 produced the opposite effects, suggesting a likely role of
XSip1 as a transcriptional repressor. One exception was the
early neural marker Sox3, whose expression was activated by
both XSip1-EnR and XSip1-VP16, the strongest induction
being observed in the case of the XSip1-VP16 protein (data not
shown). However, as Sox3 is not an exclusive neural marker,
the induced expression observed by XSip1-VP16 could
correspond to ectodermal cells. Differential regulation of Sox2
and Sox3 by Sip1 has already been previously reported in
XSip1 morphant embryos and Sip1 knockout mice (Van de
Putte et al., 2003; Snir et al., 2006).
XSip1-VP16 interferes with the activity of tBR and that of
the wild-type protein suggesting that it acts in a dominant
negative fashion. In line with this idea, XSip1-VP16 has been
previously reported to induce Xbra expression in animal caps
(Papin et al., 2002). To determine whether the absence of
induction of definitive neural markers in caps and the inhibition
of their expression in XSip1-VP16 expressing embryos might
be due to conversion of ectoderm into mesoderm, we analyzed
Xbra expression in our injected embryos and caps. In our
conditions, in caps stopped at stage 11, derived from embryos
injected at the four-cell stage using doses ranging from 100 to
500 pg/blastomere, we were unable to detect any activation of
Xbra by in situ hybridization or RT-PCR. In embryos,
expression of Xbra was even strongly inhibited at those
doses, as is the case for the native protein (data not shown).
The reason for these contradictory results is unknown. Recent
data indicate that knockdown of XSip1, while inhibiting neural
differentiation, has no effect on Xbra, suggesting that additional
factors are present in the neurectoderm that repress Xbra
expression. It has been suggested that the lack of effect of the
XSip1 morpholinos used in the latter study might be due to the
presence of the second member of the Zfhx1 family, δEF1,
which might cooperate with XSip1 to suppress Xbra in theitu analysis of animal caps and embryos analyzed for expression of Sox2 or Ep.
P RNA (250 pg/blastomere) analyzed for Sox2 expression and embryos injected
ZF-CID, NZF, and NZF-CIDmut injected embryos (250 pg/blastomere) analyzed
ip1 mRNA (100 pg/blastomere) co-injected with mSip1 CID or mSip1 CIDmut
not mSip1 CIDmut, reduces XSip1's ability to induce Sox2. A control Western
el. (D) XSip1 and CtBP-VP16 co-expressing animal caps showing reduced level
re shown in panel E. (E) Animal caps derived from embryos injected with XSip1
r co-injected with the XCtBPMO and mCtBP2 (200 pg/blastomere) analyzed for
shown as controls. The efficiency of the XCtBPMO is shown in the Western blot
ence of increasing amounts of XCtBP MO. (F) Animal caps derived from XSip1
nce of 400 nM TSA until stage 14 and then processed by in situ hybridization for
. Respective inhibition/inductions (A) 70% positive caps, n=27 for NZF-CtBP;
with NZF-GFP (n=32); (B) 60% inhibited embryos (n=25) for NZF-CID; none
(n=32) for XSip1+CID; none (n=35) for XSip1+CIDmut; (D) all with reduced
trongly positive (n=38) for XSip1; all with reduced staining (n=39) for XSip1+
one positive, n=35 for mCtBP2; (F) 85% positive caps for XSip1 (n=38) and
Fig. 7. CtBP-dependent repression of BMP4 transcription. (A) The indicated
plasmids were transfected into HEK293T cells and the cells analyzed 40 h later
for the XBMP4 promoter-driven luciferase activity. β-Galactosidase corrected
luciferase values are given. Unlike Sip1ΔSBD or wild-type Sip1, Sip13xCtBPmut
does not repress the 2-kb-long XBMP4 promoter. Control Western blots for
Myc-Sip1 protein content in the transfected cells used for the luciferase assays
are shown. (B) Effect of XSip1 and XSip13XCtBPmut on the expression of the
indicated genes analyzed by RT-PCR. Note that Xsip13XCtBPmut is less active in
BMP4 repression than the wild-type protein. Bottom panel shows the equal
expression of XSip1 and XSip13XCtBPmut in this experiment evidenced by
Western blot using anti-Myc antibodies.
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XδEF1 transcription is only activated at neurula stage, which
strongly argues against the idea that it regulates Xbra (van
Grunsven et al., 2006).
The observation that XSip1 acts as a repressor that is able to
induce the expression of neural markers in ectodermal explants
suggests that it affects these genes indirectly. This effect could
be due to its ability to repress BMP4 (Eisaki et al., 2000; Nitta et
al., 2004; Postigo et al., 2003; van Grunsven et al., 2006). Wefound that co-expression of a constitutive BMP type I receptor
inhibits XSip1's ability to induce neural markers such as Sox2
and NCAM and to repress Gata2 demonstrating that inhibition
of BMP activity or signaling is necessary for XSip1 to induce
neural tissue formation. Band shift assays showed that XSip1
can bind to the BMP4 promoter while reporter assays in
mammalian cells revealed a zinc finger and dose-dependent
repression by Sip1 of the XBMP4 promoter. Chromatin
immunoprecipitation experiments will be necessary to deter-
mine whether endogenous XSip1, in the Xenopus embryo, is
indeed bound to the BMP4 promoter and whether this accounts
for the downregulation of BMP4 within the prospective
neurectoderm. Unfortunately, no anti-Sip1 antibodies are
available yet that allow specific precipitation of endogenous
Sip1 in chromatin complexes in Xenopus. In contrast to the
effects observed on those neural markers, co-injection of CA-
Alk3 RNA did not block XSip1's ability to repress several other
superficial or deep cell specific epidermal genes, such as epi-
dermal keratin, grainyhead-like-1, TA-2, vestigial like 4 and
hyaluronan synthase 1, suggesting that XSip1 has multiple
activities, including BMP-independent functions in epidermal
inhibition. This observation is in accordance with the observa-
tions that E-cadherin and other genes coding for several
epithelial cell–cell junctions are directly repressed by Sip1
(Comijn et al., 2001; Vandewalle et al., 2005). It is not known
whether XSip1 binds to the promoters of any of those epidermal
genes. Further analysis of the promoters of these genes is
required to determine whether they are directly regulated by
XSip1.
Since the discovery of XSip1 as a Smad-binding protein, it
has been suggested that Smad–Sip1 interaction may have an
impact on Sip1-dependent gene regulation (Verschueren et al.,
1999). This interaction has been recently demonstrated to be
significant in the regulation of the Foxe3 promoter during lens
development in the mouse (Yoshimoto et al., 2005). Our
mutational analysis of XSip1 indicates that Smad recruitment is
not required for XSip1 neuralizing activity during gastrulation,
which suggests that Smad–Sip1 interaction plays a role in only
a subset of the events controlled by the multi-domain zinc finger
protein that is Sip1. In contrast, several lines of evidence
support that the co-repressor CtBP, which associates with, and is
required for, the activity of several other transcriptional re-
pressors such as TGIF and Evi1 (Alliston et al., 2005; Melhuish
and Wotton, 2000; Van Campenhout et al., 2006) plays a role in
XSip1 neuralizing properties. First, disruption of CtBP binding
motifs of XSip1 reduced its ability to neuralize animal cap
explants and abolished its capacity to repress a 2.0-kb-long
Xenopus BMP4 promoter in mammalian cells. Second, over-
expression in Xenopus of a direct fusion of mCtBP2 to one of
the DNA-binding domains of XSip1 gives the same effect as the
wild-type protein. A chimeric protein, in which one of the
DNA-binding domains of mSIP1 is fused to a polypeptide
encompassing the CtBP interacting domains, also shows some
epidermal keratin repression activity. Third, interference with
XSip1 function by out-titration of CtBPs, by using a chimeric
mCtBP2-VP16 protein or XCtBP antisense morpholino oligo-
nucleotides inhibits XSip1's ability to neuralize ectoderm.
47L.A. van Grunsven et al. / Developmental Biology 306 (2007) 34–49Fourth, one of the two CtBP family members in Xenopus,
XCtBP, is like XSip1, strongly expressed in the developing
neurectoderm during neural induction. From these observations,
we conclude that CtBP interaction plays an important role in
XSip1 activity. This is consistent with the observation that, in
CtBP knockout cells, many epithelial specific genes which are
repressed by Sip1 and δEF1 are up-regulated and can be
repressed by re-expression of CtBP (Grooteclaes et al., 2003).
The level of expression of CtBP has been recently shown to be
critical for the action of δEF1 in human colon carcinomas (Pena
et al., 2006).
CtBPs have been shown to play important roles during
Drosophila and mouse development (Bergman and Blaydes,
2006). In Xenopus, injection of mRNA encoding an anti-
morphic form of XCtBP, XCtBP/G4A, resulted in defects such
as loss of or reduced heads and/or eyes and a shortened
anterior–posterior axis (Brannon et al., 1999). We observed a
similar phenotype in CtBP MO injected embryos (data not
shown), which further suggests that the level of CtBPs is critical
for normal neural tissue development. In accordance with this
idea, we observed that CtBP genes in Xenopus, like in mouse
and birds, are highly expressed in the developing neural tissue
(Hildebrand and Soriano, 2002; Nick Van Hateren and Anne-
Gaëlle Borycki, 2006). At tadpole stages, XCtBP and XCtBP1
were found to have distinct RNA expression profiles in the
developing neural tube, by being expressed respectively in the
ventricular and marginal zones. XCtBP2 requirement during
early neural development and neurogenesis is currently under
investigation.
Our results also demonstrate that several XSip1 mutants that
are unable to induce Sox2 expression, including the CtBP
mutant, still affect epidermal keratin expression. This indicates
that XSip1 possesses additional CtBP-independent repression
activities. This also suggests that disruption of the CtBP
binding sites only quantitatively decreases XSip1's total
repressor output. In this hypothesis, the decrease of repressor
activity exerted by XSip13xCtBPmut may explain its lower
efficiency to neuralize ectodermal cells, which requires a
complete block of BMP signaling. However, it may still be
sufficiently active to affect epidermal keratin expression, which
occurs only at very high levels of BMP signaling. Other
transcriptional zinc finger repressors that recruit CtBP such as
Knirps and Ikaros also have distinct repression activities
(Deconinck et al., 2000; Struffi et al., 2004; Sutrias-Grau and
Arnosti, 2004). Isolation of additional Sip1-interacting co-
repressors (or complexes of these) will be necessary to
understand the CtBP-independent repression mechanisms of
Sip1. We also found that ventral ectodermal cells over-
producing wild-type XSip1 or CtBP mutant proteins that did
not express epidermal keratin did not adopt a neural crest or
placodal fate. Similar observations have been made in the case
of overexpression of Smad6 (Delaune et al., 2005). In the
future, it will be interesting to determine the nature of those
cells that are no longer epidermal, neural, or neural plate border
cells.
CtBPs exist as a multi-protein complex that includes the
histone-methyltransferases (HMTs) G9a and Eu-HMTase1 butalso HDAC1 and HDAC2 (Shi et al., 2003). We found that
treatment with TSA alleviates XSip1 induced expression of
Sox2 suggesting that XSip1, by interacting with CtBPs, recruits
an HDAC complex, which exerts the transcriptional repression
activity. Other studies are required to address the issue of how,
in what kind of cells, and in which order, Sip1 recruits partners
like Smads, CtBPs and other proteins to regulate target gene
expression.
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